Respiratory syncytial virus immunobiology and pathogenesis.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Virology

• Publication date

  2002-05-25

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1006/VIRO.2002.1431PMID 12083830
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Role of IFN in Respiratory Syncytial Virus Pathogenesis

  2002cited by this paper
• CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein

  2001cited by this paper
• Respiratory syncytial virus infection does not increase allergen‐induced type 2 cytokine production, yet increases airway hyperresponsiveness in mice

  2001cited by this paper
• Immunopathology in RSV infection is mediated by a discrete oligoclonal subset of antigen-specific CD4(+) T cells.

  2001cited by this paper
• Alternative Mechanisms of Respiratory Syncytial Virus Clearance in Perforin Knockout Mice Lead to Enhanced Disease

  2001cited by this paper
• Immune interaction between respiratory syncytial virus infection and allergen sensitization critically depends on timing of challenges.

  2001cited by this paper
• Surfactant protein-A enhances uptake of respiratory syncytial virus by monocytes and U937 macrophages.

  2000cited by this paper
• IL-4 Diminishes Perforin-Mediated and Increases Fas Ligand-Mediated Cytotoxicity In Vivo1

  2000cited by this paper
• Type 1‐like immune response is found in children with respiratory syncytial virus infection regardless of clinical severity

  2000cited by this paper
• Evasion of Host Defenses by Measles Virus: Wild-Type Measles Virus Infection Interferes with Induction of Alpha/Beta Interferon Production

  2000cited by this paper
• Bovine Respiratory Syncytial Virus Nonstructural Proteins NS1 and NS2 Cooperatively Antagonize Alpha/Beta Interferon-Induced Antiviral Response

  2000cited by this paper
• Pulmonary eosinophilia and production of MIP-1alpha are prominent responses to infection with pneumonia virus of mice.

  2000cited by this paper
• Priming with a Secreted Form of the Fusion Protein of Respiratory Syncytial Virus (RSV) Promotes Interleukin-4 (IL-4) and IL-5 Production but Not Pulmonary Eosinophilia following RSV Challenge

  1999cited by this paper
• Interleukin-4 Diminishes CD8+ Respiratory Syncytial Virus-Specific Cytotoxic T-Lymphocyte Activity In Vivo

  1999cited by this paper
• Induction of Th-1 and Th-2 Responses by Respiratory Syncytial Virus Attachment Glycoprotein Is Epitope and Major Histocompatibility Complex Independent

  1999cited by this paper
• Identification of a Linear Heparin Binding Domain for Human Respiratory Syncytial Virus Attachment Glycoprotein G

  1999cited by this paper
• Secreted Respiratory Syncytial Virus G Glycoprotein Induces Interleukin-5 (IL-5), IL-13, and Eosinophilia by an IL-4-Independent Mechanism

  1999cited by this paper
• Immunologic basis of antigen-induced airway hyperresponsiveness.

  1999cited by this paper
• Vaccination with pertussis toxin alters the antibody response to simultaneous respiratory syncytial virus challenge.

  1999cited by this paper
• Eliminating a Region of Respiratory Syncytial Virus Attachment Protein Allows Induction of Protective Immunity without Vaccine-enhanced Lung Eosinophilia

  1998cited by this paper
• Intracellular IFN-gamma expression in natural killer cells precedes lung CD8+ T cell recruitment during respiratory syncytial virus infection.

  1998cited by this paper
• Atypical Pulmonary Eosinophilia Is Mediated by a Specific Amino Acid Sequence of the Attachment (G) Protein of Respiratory Syncytial Virus

  1998cited by this paper
• Respiratory syncytial virus-associated infections in adult recipients of solid organ transplants.

  1998cited by this paper
• Host genetic determinants of vaccine-induced eosinophilia during respiratory syncytial virus infection.

  1998cited by this paper
• Priming with Secreted Glycoprotein G of Respiratory Syncytial Virus (RSV) Augments Interleukin-5 Production and Tissue Eosinophilia after RSV Challenge

  1998cited by this paper
• Overexpression of interleukin-4 delays virus clearance in mice infected with respiratory syncytial virus

  1997cited by this paper
• Virus-specific CD8+ T Lymphocytes Downregulate T Helper Cell Type 2 Cytokine Secretion and Pulmonary Eosinophilia during Experimental Murine Respiratory Syncytial Virus Infection

  1997cited by this paper
• CD8+ T cells control Th2‐driven pathology during pulmonary respiratory syncytial virus infection

  1997cited by this paper
• Pertussis toxin enhanced IgG1 and IgE responses to primary tetanus immunization are mediated by interleukin-4 and persist during secondary responses to tetanus alone.

  1996cited by this paper
• Generation of atypical pulmonary inflammatory responses in BALB/c mice after immunization with the native attachment (G) glycoprotein of respiratory syncytial virus

  1996cited by this paper
• Respiratory syncytial virus and influenza A infections in the hospitalized elderly.

  1995cited by this paper
• Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls.

  1995cited by this paper
• Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus.

  1994cited by this paper
• The membrane-associated and secreted forms of the respiratory syncytial virus attachment glycoprotein G are synthesized from alternative initiation codons

  1994cited by this paper
• Cytokine response to respiratory syncytial virus stimulation of human peripheral blood mononuclear cells.

  1994cited by this paper
• Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus.

  1993cited by this paper
• Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection.

  1992cited by this paper
• Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G.

  1992cited by this paper
• Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice.

  1991cited by this paper
• Respiratory Syncytial Virus‐Induced Acute Lung Injury in Adult Patients with Bone Marrow Transplants: A Clinical Approach and Review of the Literature

  1989cited by this paper
• Formalin-inactivated respiratory syncytial virus vaccine induces antibodies to the fusion glycoprotein that are deficient in fusion-inhibiting activity

  1988cited by this paper
• Role of oligosaccharides in the structure and function of respiratory syncytial virus glycoproteins

  1988cited by this paper
• Appearance of a soluble form of the G protein of respiratory syncytial virus in fluids of infected cells.

  1987cited by this paper
• Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine

  1986cited by this paper
• The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection.

  1981cited by this paper
• Cellular response to respiratory viruses with particular reference to children with disorders of cell-mediated immunity.

  1980cited by this paper
• Cell-mediated Immunity to Respiratory Syncytial Virus Induced by Inactivated Vaccine or by Infection

  1976cited by this paper
• Epidemiology of acute lower respiratory disease in children.

  1973cited by this paper
• Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine.

  1969cited by this paper
• Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population.

  1969cited by this paper

• Meeting the Challenge of Controlling Viral Immunopathology

  2024cites this paper
• Histologic Characteristics and Clinical Courses of Primary Viral Pneumonia Other than COVID-19

  2023cites this paper
• Respiratory Syncytial Virus-An Update for Prenatal and Primary Health Providers.

  2023cites this paper
• Skin and soft tissue infections

  2021cites this paper
• In silico virtual screening of lead compounds for major antigenic sites in respiratory syncytial virus fusion protein

  2021cites this paper
• A gammaherpesvirus licenses CD8 T cells to protect the host from pneumovirus-induced immunopathologies

  2020cites this paper
• Respiratory Syncytial Virus-Induced Oxidative Stress in Lung Pathogenesis

  2019cites this paper
• Contribution of Cytokines to Tissue Damage During Human Respiratory Syncytial Virus Infection

  2019cites this paper
• The antigenic and genetic variability of bovine respiratory syncytial virus with emphasis on the G protein

  2018cites this paper
• 51 – Respiratory Syncytial Virus Vaccines

  2018cites this paper
• Respiratory Viruses and Other Relevant Viral Infections in the Lung Transplant Recipient

  2018cites this paper
• 160 – Respiratory Syncytial Virus (RSV)

  2015cites this paper
• Respiratory Syncytial Virus (RSV)

  2014cites this paper
• Attenuation of live respiratory syncytial virus vaccines is associated with reductions in levels of nasal cytokines.

  2013cites this paper
• Antibodies to the Central Conserved Region of Respiratory Syncytial Virus (RSV) G Protein Block RSV G Protein CX3C-CX3CR1 Binding and Cross-Neutralize RSV A and B Strains

  2012cites this paper
• Treatment of Respiratory Syncytial Virus Infection : Past , Present and Future

  2012cites this paper
• 6. Respiratory System

  2012cites this paper
• Treatment of Respiratory Syncytial Virus Infection: Past, Present and Future

  2011cites this paper
• Cellular and Molecular Characteristics of RSV-Induced Disease in Humans

  2011influential citation
• Innate immunity proteins and a new truncated form of SPLUNC1 in nasopharyngeal aspirates from infants with respiratory syncytial virus infection

  2011cites this paper
• Immunoprotectivity of HLA-A2 CTL Peptides Derived from Respiratory Syncytial Virus Fusion Protein in HLA-A2 Transgenic Mouse

  2011cites this paper
• Toll-like receptors and interferon associated immune factors in viral haemorrhagic septicaemia virus-infected olive flounder (Paralichthys olivaceus).

  2011cites this paper
• Discovery and Development of Orally Active RSV Fusion Inhibitors

  2011cites this paper
• Reduced inflammation and altered innate response in neonates during paramyxoviral infection

  2011cites this paper
• The innate immune mechanisms underlying the interplay between respiratory infections and asthma

  2011cites this paper
• Alterations in the expression of CCSP and SPLUNC1 in the respiratory tract following viral infection of murine models

  2010influential citation
• Pulmonary Cyclooxygenase-1 (COX-1) and COX-2 Cellular Expression and Distribution After Respiratory Syncytial Virus and Parainfluenza Virus Infection

  2010cites this paper
• Viral Infections in Lung Transplant Recipients

  2010cites this paper
• Prospects for defined epitope vaccines for respiratory syncytial virus.

  2010cites this paper
• Pneumovirus and Metapneumovirus: Respiratory Syncytial Virus and Human Metapneumovirus

  2010cites this paper
• Circulating antibody-secreting cells during acute respiratory syncytial virus infection in adults.

  2010cites this paper
• Viral infections in lung transplant recipients.

  2010cites this paper
• Murine host responses to respiratory syncytial virus (RSV) following intranasal administration of a Protollin-adjuvanted, epitope-enhanced recombinant G protein vaccine.

  2009cites this paper
• Risk factors for respiratory failure associated with respiratory syncytial virus infection in adults.

  2009cites this paper
• Immunogenic properties of RSV-B1 fusion (F) protein gene-encoding recombinant adenoviruses.

  2009cites this paper
• Protective Memory Responses Are Modulated by Priming Events prior to Challenge

  2009cites this paper
• Infection of mice with respiratory syncytial virus during neonatal life primes for enhanced antibody and T cell responses on secondary challenge

  2008cites this paper
• Human and bovine respiratory syncytial virus vaccine research and development.

  2008influential citation
• Respiratory syncytial virus and influenza virus infections: observations from tissues of fatal infant cases.

  2008cites this paper
• Virology Research

  2007cites this paper
• Caracterização molecular das cepas do Vírus Sincicial Respiratório identificadas nos anos de 2001 e 2002 em unidade de transplante de células-tronco hematopoéticas

  2007cites this paper
• Severe Human Lower Respiratory Tract Illness Caused by Respiratory Syncytial Virus and Influenza Virus Is Characterized by the Absence of Pulmonary Cytotoxic Lymphocyte Responses

  2007cites this paper
• Children Infection in High-Risk Infants and Young Symptomatic Respiratory Syncytial Virus Association of TLR 4 Polymorphisms with Hemming

  2007cites this paper
• Association of TLR4 Polymorphisms with Symptomatic Respiratory Syncytial Virus Infection in High-Risk Infants and Young Children1

  2007cites this paper
• Respiratory Syncytial Virus Recombinant F Protein (Residues 255–278) Induces a Helper T Cell Type 1 Immune Response in Mice

  2007cites this paper
• Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques.

  2007cites this paper
• The role of innate immunity in protection against respiratory syncytial virus (RSV).

  2006cites this paper
• This information is current as T Cell Responses + CX 3 CR 1 Protein CX 3 C Motif Adversely Affect Respiratory Syncytial Virus G Protein and

  2006cites this paper
• The rabies virus phosphoprotein P: a key regulator of innate immune responses

  2006cites this paper
• T Cell Responses to Respiratory Syncytial Virus Fusion and Attachment Proteins in Human Peripheral Blood Mononuclear Cells

  2006cites this paper
• Effects of alveolar macrophage depletion on liposomal vaccine protection against respiratory syncytial virus (RSV)

  2006cites this paper
• Respiratory Syncytial Virus G Protein and G Protein CX3C Motif Adversely Affect CX3CR1+ T Cell Responses

  2006cites this paper
• Respiratory syncytial virus and innate immunity: a complex interplay of exploitation and subversion

  2006cites this paper
• Formulation with CpG oligodeoxynucleotides increases cellular immunity and protection induced by vaccination of calves with formalin-inactivated bovine respiratory syncytial virus.

  2006cites this paper
• Human Parainfluenza Virus 3 Neuraminidase Activity Contributes to Dendritic Cell Maturation

  2005cites this paper
• Carriers for the delivery of a vaccine against respiratory syncytial virus

  2005cites this paper
• Perspective on the host response to human metapneumovirus infection: what can we learn from respiratory syncytial virus infections?

  2005cites this paper
• Identification of an H-2D(b)-restricted CD8+ cytotoxic T lymphocyte epitope in the matrix protein of respiratory syncytial virus.

  2005cites this paper
• Identification of an H-2Db-restricted CD8+ cytotoxic T lymphocyte epitope in the matrix protein of respiratory syncytial virus

  2005cites this paper
• Modulation of Protective Immunity, Eosinophilia, and Cytokine Responses by Selective Mutagenesis of a Recombinant G Protein Vaccine against Respiratory Syncytial Virus

  2005cites this paper
• Inhibition of Toll-Like Receptor 7- and 9-Mediated Alpha/Beta Interferon Production in Human Plasmacytoid Dendritic Cells by Respiratory Syncytial Virus and Measles Virus

  2005cites this paper
• Mobilization of plasmacytoid and myeloid dendritic cells to mucosal sites in children with respiratory syncytial virus and other viral respiratory infections.

  2005cites this paper
• Respiratory Syncytial Virus Infection in Adults

  2005cites this paper
• Respiratory syncytial virus infection in children hospitalized for wheezing: Virus‐specific studies from infancy to preschool years

  2005cites this paper
• This information is current as Infection Illness during Respiratory Syncytial Virus Exacerbates α Prolonged Production of TNF -

  2004cites this paper
• Identification of a Common HLA-DP4-Restricted T-Cell Epitope in the Conserved Region of the Respiratory Syncytial Virus G Protein

  2004cites this paper
• Construction of adenoviral vectors expressing F and G glycoproteins of human respiratory syncytial virus (HRSV)

  2004cites this paper
• Oral Efficacy of a Respiratory Syncytial Virus Inhibitor in Rodent Models of Infection

  2004cites this paper
• trans-Complementation Allows Recovery of Human Respiratory Syncytial Viruses That Are Infectious but Deficient in Cell-to-Cell Transmission

  2004cites this paper
• Pathogenesis of Respiratory Syncytial Virus Infection

  2004cites this paper
• Vβ14+ T Cells Mediate the Vaccine-Enhanced Disease Induced by Immunization with Respiratory Syncytial Virus (RSV) G Glycoprotein but Not with Formalin-Inactivated RSV

  2004cites this paper
• Treatment with Anti-LFA-1 Delays the CD8+ Cytotoxic-T-Lymphocyte Response and Viral Clearance in Mice with Primary Respiratory Syncytial Virus Infection

  2004cites this paper
• Evaluation of BBG2Na in infant macaques: specific immune responses after vaccination and RSV challenge.

  2004cites this paper
• Prolonged Production of TNF-α Exacerbates Illness during Respiratory Syncytial Virus Infection1

  2004cites this paper
• Respiratory Syncytial Virus (RSV) G Glycoprotein Is Not Necessary for Vaccine-Enhanced Disease Induced by Immunization with Formalin-Inactivated RSV

  2004cites this paper
• Prolonged Production of TNF-

  2004cites this paper
• Antibody-dependent enhancement, a possible mechanism in augmented pulmonary disease of respiratory syncytial virus in the Bonnet monkey model.

  2003cites this paper
• The antigenic and genetic variability of bovine respiratory syncytial virus with emphasis on the G protein

  2003cites this paper
• Increased susceptibility to RSV infection by exposure to inhaled diesel engine emissions.

  2003cites this paper
• Respiratory syncytial virus in healthy adults: the cost of a cold.

  2003cites this paper
• Infectivity of a Human Respiratory Syncytial Virus Lacking the SH, G, and F Proteins Is Efficiently Mediated by the Vesicular Stomatitis Virus G Protein

  2003cites this paper
• Enhanced Disease and Pulmonary Eosinophilia Associated with Formalin-Inactivated Respiratory Syncytial Virus Vaccination Are Linked to G Glycoprotein CX3C-CX3CR1 Interaction and Expression of Substance P

  2003cites this paper
• Specific history of heterologous virus infections determines anti-viral immunity and immunopathology in the lung.

  2003cites this paper
• Pathogenesis and Immune Response

  2002cites this paper
• T Cell Responses + Cx3cr1 Protein Cx3c Motif Adversely Affect Respiratory Syncytial Virus G Protein and G

  year unknowncites this paper